{{BCKData.LocationHeading}}

  • {{ !!location.countrycode?location.countryName :location.officeName }}

{{headerData.hamburgerPrimaryFeatureHeading}}

{{headerData.hamburgerSecondaryFeatureHeading}}

Dentons advises STADA group on acquisition of US$660 million pharmaceutical portfolio from Takeda in 11 countries, including Russia and CIS

Pharmaceuticals
Pharmaceuticals
 

Redirection

You are switching to another language. Please click Confirm below to continue.

 
Important Notice